Cargando…
NOTUM is a potential pharmacodynamic biomarker of Wnt pathway inhibition
Activation of Wnt signaling due to Wnt overexpression or mutations of Wnt pathway components is associated with various cancers. Blocking Wnt secretion by inhibiting PORCN enzymatic activity has shown efficacy in a subset of cancers with elevated Wnt signaling. Predicting response to upstream Wnt in...
Autores principales: | Madan, Babita, Ke, Zhiyuan, Lei, Zheng Deng, Oliver, Frois Ashley, Oshima, Masanobu, Lee, May Ann, Rozen, Steve, Virshup, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914292/ https://www.ncbi.nlm.nih.gov/pubmed/26848981 http://dx.doi.org/10.18632/oncotarget.7157 |
Ejemplares similares
-
Structural characterization of melatonin as an inhibitor of the Wnt deacylase Notum
por: Zhao, Yuguang, et al.
Publicado: (2020) -
Carboxylesterase
Notum Is a Druggable Target to Modulate
Wnt Signaling
por: Bayle, Elliott D., et al.
Publicado: (2021) -
WNT inhibition creates a BRCA‐like state in Wnt‐addicted cancer
por: Kaur, Amanpreet, et al.
Publicado: (2021) -
Notum deacylates octanoylated ghrelin
por: Zhao, Yuguang, et al.
Publicado: (2021) -
Structural Insights
into Notum Covalent Inhibition
por: Zhao, Yuguang, et al.
Publicado: (2021)